Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Robert Davis
Pharma
Merck CEO Davis touts potential of CV drug candidates
A day after he was named Merck's next chairman, in addition to his CEO duties, Rob Davis touted his efforts to beef up the company's pipeline.
Kevin Dunleavy
Oct 27, 2022 12:02pm
Nothing to Seagen here: Merck remains mum on merger
Jul 28, 2022 11:04am
Most influential people in biopharma—the CEOs
May 2, 2022 3:00am
Romanelli returns to Merck to head up international human health
Apr 20, 2022 9:06am
Merck, during a transition year, doled out nearly $30M to CEOs
Apr 5, 2022 11:58am
How did Merck record an 11% tax rate last year?
Apr 5, 2022 10:33am
